Fauzia Ullah

429 total citations
26 papers, 210 citations indexed

About

Fauzia Ullah is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Fauzia Ullah has authored 26 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Fauzia Ullah's work include CAR-T cell therapy research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Fauzia Ullah is often cited by papers focused on CAR-T cell therapy research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Fauzia Ullah collaborates with scholars based in United States, Italy and France. Fauzia Ullah's co-authors include Danai Dima, Jack Khouri, Faiz Anwer, Shahzad Raza, Mariam Markouli, Jaroslaw P. Maciejewski, Metis Hasipek, Babal K. Jha, Suneel D. Kamath and Emrullah Yilmaz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Fauzia Ullah

21 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fauzia Ullah United States 10 118 66 58 39 34 26 210
Sigrún Þorsteinsdóttir Denmark 7 71 0.6× 79 1.2× 96 1.7× 26 0.7× 32 0.9× 17 207
Elizabeth H. Cull United States 9 100 0.8× 101 1.5× 117 2.0× 19 0.5× 14 0.4× 27 272
Vishala T. Neppalli United States 8 94 0.8× 62 0.9× 49 0.8× 85 2.2× 12 0.4× 22 221
Elizabeth Brém United States 10 112 0.9× 86 1.3× 36 0.6× 93 2.4× 16 0.5× 35 270
Minh Tran United States 6 141 1.2× 80 1.2× 35 0.6× 20 0.5× 21 0.6× 13 259
Paola Minetto Italy 10 97 0.8× 72 1.1× 85 1.5× 14 0.4× 11 0.3× 39 254
Daniela Caravelli Italy 7 132 1.1× 43 0.7× 29 0.5× 16 0.4× 18 0.5× 13 217
Dipenkumar Modi United States 10 129 1.1× 31 0.5× 132 2.3× 64 1.6× 13 0.4× 61 272
Rossana Putzulu Italy 9 51 0.4× 157 2.4× 133 2.3× 32 0.8× 17 0.5× 26 295
Raetasha Dabney United States 7 103 0.9× 55 0.8× 20 0.3× 14 0.4× 26 0.8× 12 197

Countries citing papers authored by Fauzia Ullah

Since Specialization
Citations

This map shows the geographic impact of Fauzia Ullah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fauzia Ullah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fauzia Ullah more than expected).

Fields of papers citing papers by Fauzia Ullah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fauzia Ullah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fauzia Ullah. The network helps show where Fauzia Ullah may publish in the future.

Co-authorship network of co-authors of Fauzia Ullah

This figure shows the co-authorship network connecting the top 25 collaborators of Fauzia Ullah. A scholar is included among the top collaborators of Fauzia Ullah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fauzia Ullah. Fauzia Ullah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dima, Danai, Fauzia Ullah, Beth Faiman, et al.. (2025). Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14‐Year Experience of an Academic Center. Hematological Oncology. 43(3). e70082–e70082.
3.
Ullah, Fauzia, et al.. (2024). Immunotherapy for Head and Neck Squamous Cell Carcinoma: Present and Future Approaches and Challenges. JCO Oncology Practice. 20(12). 1588–1595. 11 indexed citations
4.
Gurnari, Carmelo, Hussein Awada, Simona Pagliuca, et al.. (2024). Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis. Blood. 144(2). 145–155. 6 indexed citations
5.
Dima, Danai, Fauzia Ullah, Xuefei Jia, et al.. (2024). Real‐world outcomes of patients with resected stage III melanoma treated with adjuvant therapies. Cancer Medicine. 13(12). e7257–e7257. 2 indexed citations
6.
Ullah, Fauzia, et al.. (2024). Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment. Cancers. 16(7). 1307–1307. 4 indexed citations
7.
Kawashima, Naomi, Carmelo Gurnari, Carlos Bravo‐Pérez, et al.. (2024). Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. 39(2). 451–459. 2 indexed citations
8.
Awada, Hussein, Arda Durmaz, Tariq Kewan, et al.. (2024). Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis. Leukemia. 38(6). 1411–1414.
10.
Dima, Danai, Michael S. Hughes, Fauzia Ullah, et al.. (2024). Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy. Amyloid. 31(3). 195–201. 4 indexed citations
11.
Ullah, Fauzia, et al.. (2023). Advances in the treatment of Hodgkin lymphoma: Current and future approaches. Frontiers in Oncology. 13. 1067289–1067289. 11 indexed citations
12.
Ullah, Fauzia, et al.. (2023). Early-Onset Colorectal Cancer: Current Insights. Cancers. 15(12). 3202–3202. 36 indexed citations
13.
Dima, Danai, et al.. (2023). Precision Oncology Targets in Biliary Tract Cancer. Cancers. 15(7). 2105–2105. 13 indexed citations
14.
Ullah, Fauzia, et al.. (2023). Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism. The Oncologist. 28(11). e1005–e1016. 1 indexed citations
15.
Dima, Danai, Fauzia Ullah, Louis Williams, et al.. (2023). Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice. Cancers. 15(7). 2160–2160. 16 indexed citations
16.
17.
Dima, Danai, Fauzia Ullah, Hussein Awada, et al.. (2023). Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis. Blood. 142(Supplement 1). 2031–2031. 3 indexed citations
18.
Ullah, Fauzia, Danai Dima, Carmelo Gurnari, et al.. (2022). Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia. Blood. 140(Supplement 1). 5795–5796. 2 indexed citations
19.
Ullah, Fauzia, et al.. (2021). Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease. Digestive Diseases and Sciences. 67(7). 3333–3339. 11 indexed citations
20.
Ullah, Fauzia, et al.. (2020). Longitudinal investigation of Distress Thermometer scores in patients with cancer.. Journal of Clinical Oncology. 38(15_suppl). e24200–e24200.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026